Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vericel CorpVCEL · Entity 4481 | Director | April 29, 2026 | May 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vericel Corp
Report date April 29, 2026 · Filed May 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,851 |
Reported balance
After 2026-04-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-04-29 · Exercise / conversion · Acquired 3,200 · Balance 15,851 F1: The Restricted Stock Units (RSUs) converted to Phantom Stock units and are deferred under the Vericel Corporation Deferred Compensation Plan. The units will be payable only in shares of Common Stock upon the Reporting Person's elected Benefit Distribution Date. F2: Upon the vesting of RSUs granted to the Reporting Person on April 30, 2025, the Reporting Person deferred the receipt of 3,200 shares of Common Stock and instead received 3,200 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-04-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-29 · Exercise / conversion · Acquired 3,200 · Balance 0 F3: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F2: Upon the vesting of RSUs granted to the Reporting Person on April 30, 2025, the Reporting Person deferred the receipt of 3,200 shares of Common Stock and instead received 3,200 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan. F4: These RSUs vest 100% on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025. F5: No expiration date for this type of award. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 3,200 |
Reported balance
After 2026-04-29 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-04-29 · Grant · Acquired 3,200 · Balance 3,200 F3: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F7: These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders following April 29, 2026. F5: No expiration date for this type of award. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.43 · Expires 2036-04-29 | Direct | 8,000 |
Reported balance
After 2026-04-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-29 · Grant · Acquired 8,000 · Balance 8,000 F6: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units (RSUs) converted to Phantom Stock units and are deferred under the Vericel Corporation Deferred Compensation Plan. The units will be payable only in shares of Common Stock upon the Reporting Person's elected Benefit Distribution Date.
F2: Upon the vesting of RSUs granted to the Reporting Person on April 30, 2025, the Reporting Person deferred the receipt of 3,200 shares of Common Stock and instead received 3,200 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan.
F3: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
F4: These RSUs vest 100% on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025.
F5: No expiration date for this type of award.
F6: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.
F7: These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders following April 29, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 29, 2026 Filed May 1, 2026 20:06 UTC | Vericel Corp VCEL · Entity 4481 | GrantRestricted Stock Unit · Derivative | 3,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-018539 · form4.xml · derivative · entry 4 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,200 Underlying: Common Stock · 3,200 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F7 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders following April 29, 2026. F5 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 29, 2026 Filed May 1, 2026 20:06 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $33.43 | $0.00 |
DisclosureSEC source: 0001140361-26-018539 · form4.xml · derivative · entry 3 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2036-04-29 F6 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| April 29, 2026 Filed May 1, 2026 20:06 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 3,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-26-018539 · form4.xml · derivative · entry 2 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F2 · price: Upon the vesting of RSUs granted to the Reporting Person on April 30, 2025, the Reporting Person deferred the receipt of 3,200 shares of Common Stock and instead received 3,200 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan. F4 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025. F5 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 29, 2026 Filed May 1, 2026 20:06 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 3,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-26-018539 · form4.xml · nonDerivative · entry 1 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Restricted Stock Units (RSUs) converted to Phantom Stock units and are deferred under the Vericel Corporation Deferred Compensation Plan. The units will be payable only in shares of Common Stock upon the Reporting Person's elected Benefit Distribution Date. F2 · price: Upon the vesting of RSUs granted to the Reporting Person on April 30, 2025, the Reporting Person deferred the receipt of 3,200 shares of Common Stock and instead received 3,200 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan. Read SEC document |
| April 30, 2025 Filed May 2, 2025 20:07 UTC | Vericel Corp VCEL · Entity 4481 | GrantRestricted Stock Unit · Derivative | 3,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-017115 · form4.xml · derivative · entry 4 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,200 Underlying: Common Stock · 3,200 shares Expires not disclosed F2 · derivative.exercise_price: Upon the vesting of RSUs granted to the Reporting Person on May 1, 2024, the Reporting Person deferred the receipt of 3,200 shares of Common Stock and instead received 3,200 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan. F7 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025. F5 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 30, 2025 Filed May 2, 2025 20:07 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $38.02 | $0.00 |
DisclosureSEC source: 0001140361-25-017115 · form4.xml · derivative · entry 3 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2035-04-30 F6 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| April 30, 2025 Filed May 2, 2025 20:07 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 3,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-25-017115 · form4.xml · derivative · entry 2 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F2 · price: Upon the vesting of RSUs granted to the Reporting Person on May 1, 2024, the Reporting Person deferred the receipt of 3,200 shares of Common Stock and instead received 3,200 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan. F4 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2025, or the date of the first Annual Meeting of Stockholders following May 1, 2024. F5 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 30, 2025 Filed May 2, 2025 20:07 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 3,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-25-017115 · form4.xml · nonDerivative · entry 1 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Restricted Stock Units (RSUs) converted to Phantom Stock units and are deferred under the Vericel Corporation Deferred Compensation Plan. The units will be payable only in shares of Common Stock upon the Reporting Person's elected Benefit Distribution Date. F2 · price: Upon the vesting of RSUs granted to the Reporting Person on May 1, 2024, the Reporting Person deferred the receipt of 3,200 shares of Common Stock and instead received 3,200 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:05 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 434 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-029005 · form4.xml · derivative · entry 2 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 434 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest in equal annual installments over three years, beginning on June 1, 2021. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:05 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 434 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-24-029005 · form4.xml · nonDerivative · entry 1 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on June 1, 2021. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:06 UTC | Vericel Corp VCEL · Entity 4481 | GrantRestricted Stock Unit · Derivative | 3,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-024335 · form4.xml · derivative · entry 4 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,200 Underlying: Common Stock · 3,200 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F6 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2025, or the date of the first Annual Meeting of Stockholders following May 1, 2024. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:06 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $47.08 | $0.00 |
DisclosureSEC source: 0001140361-24-024335 · form4.xml · derivative · entry 3 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2034-05-01 F5 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:06 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 3,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-024335 · form4.xml · derivative · entry 2 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 3, 2024, or the date of the first Annual Meeting of Stockholders following May 3, 2023. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:06 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 3,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-24-024335 · form4.xml · nonDerivative · entry 1 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on May 3, 2023. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 20:03 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 433 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-028018 · form4.xml · derivative · entry 2 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 434 Underlying: Common Stock · 433 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest in equal annual installments over three years, beginning on June 1, 2021. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 20:03 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 433 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-028018 · form4.xml · nonDerivative · entry 1 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on June 1, 2021. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:05 UTC | Vericel Corp VCEL · Entity 4481 | GrantRestricted Stock Unit · Derivative | 3,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-023194 · form4.xml · derivative · entry 2 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,200 Underlying: Common Stock · 3,200 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 3, 2024 or the date of the first Annual Meeting of Stockholders following May 3, 2023. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:05 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $32.12 | $0.00 |
DisclosureSEC source: 0001140361-23-023194 · form4.xml · derivative · entry 1 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2033-05-03 F1 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| April 27, 2023 Filed Apr 28, 2023 20:04 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-021503 · form4.xml · derivative · entry 2 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 27, 2023 or the date of the first Annual Meeting of Stockholders following April 27, 2022. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 27, 2023 Filed Apr 28, 2023 20:04 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 2,600 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-021503 · form4.xml · nonDerivative · entry 1 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 27, 2022. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 20:04 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 433 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-22-001058 · primary_01.xml · derivative · entry 2 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 867 Underlying: Common Stock · 433 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest in equal annual installments over three years, beginning on June 1, 2021. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 20:04 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 433 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001593968-22-001058 · primary_01.xml · nonDerivative · entry 1 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on June 1, 2021. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 20:22 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (right to buy) · Derivative | 6,500 | $0.00 Strike: $31.99 | $0.00 |
DisclosureSEC source: 0001593968-22-000894 · primary_01.xml · derivative · entry 4 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 6,500 shares Expires 2032-04-27 F6 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 20:22 UTC | Vericel Corp VCEL · Entity 4481 | GrantRestricted Stock Unit · Derivative | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-22-000894 · primary_01.xml · derivative · entry 3 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Underlying: Common Stock · 2,600 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F5 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 27, 2023 or the date of the first Annual Meeting of Stockholders following April 27, 2022. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 20:22 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionRestricted Stock Unit · Derivative | 2,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-22-000894 · primary_01.xml · derivative · entry 2 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,351 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of April 28, 2022 or the date of the first Annual Meeting of Stockholders following April 28, 2021. The first Annual Meeting of Stockholders occurred on April 27, 2022. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 20:22 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 2,351 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001593968-22-000894 · primary_01.xml · nonDerivative · entry 1 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:15 UTC | Vericel Corp VCEL · Entity 4481 | GrantRestricted Stock Unit · Derivative | 2,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-21-001515 · primary_01.xml · derivative · entry 4 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,351 Underlying: Common Stock · 2,351 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F6 · derivative.exercise_date: These RSUs shall vest on the earlier of June 1, 2022 or the date of the Company's next annual meeting of shareholders, contingent upon continued service to the Company. F3 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:15 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (right to buy) · Derivative | 5,877 | $0.00 Strike: $56.49 | $0.00 |
DisclosureSEC source: 0001593968-21-001515 · primary_01.xml · derivative · entry 3 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,877 Underlying: Common Stock · 5,877 shares Expires 2031-06-01 F5 · derivative.exercise_date: These options, representing the right to purchase a total of 5,877 shares, shall vest and become exercisable in equal monthly installments beginning on June 1, 2021, and shall become fully vested and exercisable on the earlier of the date of the Company's next annual meeting of shareholders or April 27, 2022, contingent upon continued service to the Company. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:15 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (right to buy) · Derivative | 3,250 | $0.00 Strike: $56.49 | $0.00 |
DisclosureSEC source: 0001593968-21-001515 · primary_01.xml · derivative · entry 2 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,250 Underlying: Common Stock · 3,250 shares Expires 2031-06-01 F4 · derivative.exercise_date: These options, representing the right to purchase a total of 3,250 shares, shall vest and become exercisable in equal monthly installments over three years, beginning on June 1, 2021, contingent upon continued service to the Company. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:15 UTC | Vericel Corp VCEL · Entity 4481 | GrantRestricted Stock Unit · Derivative | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-21-001515 · primary_01.xml · derivative · entry 1 WRIGHT LISA · CIK 0001865017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Underlying: Common Stock · 1,300 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F2 · derivative.exercise_date: These RSUs vest in equal annual installments over three years, beginning on June 1, 2021. F3 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.